Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene adjunctive treatment for negative symptoms of schizophrenia in postmenopausal women
2011-000245-20Phase 3Completed
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of raloxifene in schizophrenia (2 arms), sponsored by Fundació Sant Joan de Déu. Primary endpoint: Primary efficacy endpoint. Started Jan 2012; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2011-000245-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000245-20.